Navigation Links
Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
Date:3/13/2008

101,400

Operating expenses:

Research and development 1,527,457 5,124,292

General and administrative 1,193,180 4,477,567

Total operating expenses 2,720,637 9,601,859

Loss from operations 2,720,637 9,500,459

Basic and diluted operating

loss per share (0.11) (0.56)

Interest income (net) 204,071 (802,336)

Net loss (2,516,566) (10,302,795)

Basic and diluted loss per share (0.10) (0.61)

Weighted-average common

shares outstanding 24,099,716 16,942,142

SUMMARY BALANCE SHEET DATA

December 31, 2007

Cash and cash equivalents 16,233,464

Total assets 17,089,328

Stockholders' equity 15,199,931


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
2. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
3. Proteon Therapeutics Receives European Patent Covering New Method of Dilating Arteries and Veins
4. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
5. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
6. Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
7. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
8. Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products
9. Nile Therapeutics to Announce 2007 Fourth Quarter and Full Year Financial Results on Thursday, March 13, 2008
10. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
11. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Synthetic Biologics, Inc. (NYSE ... serious infections and diseases, with a focus on ... supporting the development of SYN-004, the Company,s candidate ... antibiotics within the gastrointestinal (GI) tract and maintain ... the prevention of C. difficile infection, ...
(Date:4/1/2015)... CITY and LONDON , April ... research reports and solutions, MarketResearch.com is pleased to highlight a ... a year of market growth and opportunity for the stem ... company or cord blood bank, competing in the stem cell ... predict industry trends, and act on market changes before the ...
(Date:4/1/2015)... National recruitment firm Slone Partners is pleased ... of Sales at Optimal Medicine, an international digital health ... brings over 20 years experience in healthcare information technology ... including Dell Services Healthcare, Medsphere Systems and McKesson. ... for accomplishing the goals Optimal Medicine had for this ...
(Date:3/31/2015)... Fla. , March 31, 2015  Biotest Pharmaceuticals ... is pleased to announce the addition of its newest ... Suite 205 Conway, Arkansas . The ... doors for business on March 26 th 2015 ... centers to eighteen. "This facility represents ...
Breaking Biology Technology:Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4Slone Partners Fills Head of Sales at Optimal Medicine 2Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2
... have designed, developed and tested new molecular tools for stem ... for use in drug development programmes. , A collaborative ... England Stem Cell Institute (NESCI) have developed two synthetic molecules ... - that is, transform into other forms of tissue. ...
... Using two abundant and relatively inexpensive elements, ... webbing of nano-scale wires that multiplies surface area ... in electronics and energy applications. , , Researchers grew ... network of branches that resemble flat, rectangular netting, ...
... SOUTH SAN FRANCISCO, Calif., Sept. 2 Anesiva,Inc. ... Houghton, M.D. has joined,the company as senior vice ... Anesiva,s clinical and regulatory functions., "Bill brings ... pain management products, and a medical background in,anesthesiology," ...
Cached Biology Technology:New stem cell tools to aid drug development 2New stem cell tools to aid drug development 3Scientists grow 'nanonets' able to snare added energy transfer 2Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer 2
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/10/2015)... -- Continuing its 167-year history of offering the Best, the ... Eye Scanning Password Authenticator , a device that confirms ... or sensitive data. Employing the same biometric ... device has a small camera that scans and saves ... them into an encrypted ID that cannot be forged ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... (21 March 2013)A new study reveals that governments in ... fuel developmentwhile paying scant attention to the impact mining, ... or on the people who own the land. The ... was released at the 14th Rights and Resources Initiative ...
... the Johns Hopkins University Applied Physics Laboratory (APL) ... dengue fever outbreaks several weeks before they occur. ... Infectious Disease Scalable Model (PRISM), extracts relationships between ... and in the Philippines. It can be used ...
... of the most common human excreta disposal systems globally, ... aim to meet the sanitation-related target of the Millennium ... these basic toilets as a way to improve human ... disease-causing microbes or other contaminants to leach into the ...
Cached Biology News:Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment 2Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment 3Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment 4APL novel method accurately predicts disease outbreaks 2Additional research must be done to ensure safety of pit latrines, new study says 2
Recombinant Mouse LIGHT/TNFSF14...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Request Info...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Biology Products: